chrisvoncsefalvay/vaers-outcomes huggingface dataset:
chills; fever; Shaking; confusion; This is a spontaneous report obtained from a contactable physician through a Pfizer sales representative.  A male patient of an unspecified age (in his late 60's or early 70's) received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) at single dose and influenza vaccine, both on the same date, in different arms, for immunization. Relevant medical history and concomitant medications were unknown. On an unspecified date, after the vaccinations, the patient experienced chills, fever, shaking, and confusion. The patient went to the emergency room (ER) for testing and was discharged the next day with antibiotics. Clinical outcome of the adverse events was unknown at time of this report.  The information on the lot number has been requested.
Left arm injection site swelling and erythema with superficial blisters onset 1 week after vaccine administration
After the first dose which should be recorded, I experienced shortness of breath and my heart was racing badly. After the second dose on January 12, 2021, I experienced the same issues along with feeling extremely tired. Approximately 3 weeks later, I had a rash that started on my inner arms which then spread over my torso, chest, breasts, and lower legs. The rash remained for 7 weeks. I then continued to have rashes for 6 to 7 weeks and a break in between that varied between 3 to 4 weeks. I mentioned this to my previous doctor's nurse practitioner who said the rashes were not from an allergy but looked to be from the vaccine. In addition, my a-fib which was very controlled with 10mg of metoprolol once daily, had to be changed to 20mg twice daily. It's been 3 and a half years since getting the vaccine and I must take my heart medication twice daily, and I still experience these rashes. Currently, the rash is on my inner arms, lower legs, face, neck, ears, chest, and torso. I wouldn't wish this raw, red, itchy rash on my worst enemy. It's horrible! And to have my heart race all over the place is equally upsetting.
Pulse rate in the 160s, BP elevated 160/100 (this was a few hours after feeling sick and starting to feel better. Vomited x2. Dizzy, blurred vision. I have had elevated pulse like this prior bit never lasting for hours going through cycles of this. Horrible headache next day and completely wiped out. 4 days later still feel exhausted. I still get dizzy/fuzzy if I bend over.  Called cardiologist and they had me take heart med to lower my pulse. Made appt to be seen.
HEADACHE; DIZZINESS; BLURRED VISION; SHORTNESS OF BREATHE; CHEST TIGHTNESS; EUPHORIA; UNCOORDINATION; BODY ACHES AND BODY PAIN; FATIGUE AND FELT TRIED; NAUSEA; SEVERE MIGRAINE; SORES ON TONGUE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included clenching of the jaws.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 1805020 expiry: UNKNOWN) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced sores on tongue. On 01-APR-2021, the subject experienced severe migraine. On 01-APR-2021, the subject experienced euphoria. On 01-APR-2021, the subject experienced uncoordination. On 01-APR-2021, the subject experienced body aches and body pain. On 01-APR-2021, the subject experienced fatigue and felt tried. On 01-APR-2021, the subject experienced nausea. On 03-APR-2021, the subject experienced shortness of breathe. On 03-APR-2021, the subject experienced chest tightness. On 11-APR-2021, the subject experienced dizziness. On 11-APR-2021, the subject experienced blurred vision. On 15-APR-2021, Laboratory data included: MRI (NR: not provided) NEGATIVE. On an unspecified date, the subject experienced headache. Treatment medications (dates unspecified) included: meglumine gadoterate. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from shortness of breathe, and chest tightness on 04-APR-2021, euphoria, uncoordination, body aches and body pain, and nausea on 03-APR-2021, and dizziness, and blurred vision on APR-2021, had not recovered from severe migraine, fatigue and felt tried, and headache, and the outcome of sores on tongue was not reported. This report was non-serious.
This spontaneous report was received from a licensed vocational nurse and refers to multiple unspecified patients of unknown age and gender. The patients' pertinent medical history, drug reactions or allergies and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL 9. The administered doses experienced a temperature excursion of 34.7 degrees Fahrenheit for 2 hours. There was no previous temperature excursion. The stored vaccines were back in proper temperature range. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
On day following DTaP #2, patient had 30 minute episode of fever, decreased responsiveness and pallor. Patient seen in office; was normal later the same day. Fever 102 per mom.
Patient received 2nd dose pfizer shot on her right arm on 8/19/2021. Ever since her 2nd dose, her right arm has been on and off hurting. There are times that she cannot move or lift her right arm and that area hurts really bad. The pain goes away for a few weeks and comes right back for another week. It is now getting very bad now that she is going to see her doctor. She has tried NSAIDS meds and cold and hot compressions and more but nothing does help to go away completely.
yellow/green bruise at injection site; yellow/green bruise at injection site; arm itches; 3 inch by 4 inch welt below the injection site; could barely chew; facial swelling near lip; herpes labialis flare up triggered by vaccine/suspected/possible herpes labialis flare up.; body aches; severe pain at the injection site; low grade fever; This case was reported by a nurse via call center representative and described the occurrence of injection site discoloration in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included herpes labialis.   On 28th July 2022, the patient received the 1st dose of Shingrix (intramuscular) .5 mg/ml. On 28th July 2022, less than a day after receiving Shingrix, the patient experienced injection site pain, general body pain and fever. On 3rd August 2022, the patient experienced herpes labialis, chewing difficulty and facial swelling. On an unknown date, the patient experienced injection site discoloration, injection site bruising, itchy upper limbs and welts. On an unknown date, the outcome of the injection site discoloration, injection site bruising, injection site pain, itchy upper limbs, facial swelling and welts were not recovered/not resolved and the outcome of the herpes labialis and chewing difficulty were unknown and the outcome of the general body pain and fever were recovered/resolved.   It was unknown if the reporter considered the injection site discoloration, injection site bruising, injection site pain, general body pain, itchy upper limbs, chewing difficulty, facial swelling, welts and fever to be related to Shingrix. The reporter considered the herpes labialis to be related to Shingrix.     Additional Information: GSK Receipt Date: 04-AUG-202 Reporter's Comment: The reporter herself was the patient and nurse also. On 28th July 2022 she had received her first Shingrix dose and had experienced severe pain at the injection site, described it was a ton of lead being pushed into her arm.  She had experienced a low grade fever and body aches after the injection. She had developed a 3 inch by 4-inch welt below the injection site. She now had a yellow/green bruise at the injection site.  Her arm itches. The day before reporting on 3rd August 2022 she had developed facial swelling near her lip and could barely chew (AE: swelling, not recovered). She believed that the facial swelling was a herpes labialis flare up triggered by the Shingrix vaccine. She had nothing else to report. The reporter consented to follow-up but does not had a consented physician at this time. Additional supportive information: The time taken to onset for injection site bruising, injection site pain, general body pain, pruritus, welts and fever was captured as Less than a day and for herpes labialis, facial swelling and chewing difficulty it was captured as 6 days.
I developed a headache across my forehead around 8:30pm that night 4/15/21 from 12:10pm vaccination.  I didn't take any medication.  I applied peppermint essential oil with no relief.  The headache was still present in the morning now with nausea from the headache.   I do not normally get headaches.  I took pamprin at 7:30am 4/16/21 and ate breakfast.  The headache has dissipated, however I feel it in the background and I am very cold.  My temperature is 98.2.  I am no longer nauseous.  My atlas was out of alignment so I was adjusted by a chiropractic clinic.  I will await to see if my headache returns or for other symptoms and take pamprin if necessary again.
report breastfeeding; This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE VIA BREAST MILK (report breastfeeding) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20A and 041L20A) for COVID-19 vaccination.    MEDICAL HISTORY (Parent): The patient reported having given birth a week prior to her first vaccine.  Concurrent medical conditions included Maternal exposure during breast feeding.    MEDICAL HISTORY (Patient): No medical history was provided by reporter.  Concomitant products included ENOXAPARIN SODIUM (LOVENOX HP) for Anticoagulant therapy, ACETYLSALICYLIC ACID (BABY ASPIRIN), LEVOTHYROXINE and PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for an unknown indication.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EXPOSURE VIA BREAST MILK (report breastfeeding). At the time of the report, EXPOSURE VIA BREAST MILK (report breastfeeding) outcome was unknown. Not Provided
patient reported reduced pain all over her body, describes it as 25% of the pain that she felt before she go the vaccine and feels very good right now. states she wanted to report this "good" side effect
Vaginal cold sore; This non-serious case was reported by a nurse via call center representative and described the occurrence of vaginal lesion in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included genital herpes. Concomitant products included valaciclovir (Valacyclovir).   On 12-JUN-2023, the patient received the 1st dose of Shingrix (intramuscular, left arm). On 13-JUN-2023, 1 days after receiving Shingrix, the patient experienced vaginal lesion (Verbatim: Vaginal cold sore). The outcome of the vaginal lesion was not resolved.   It was unknown if the reporter considered the vaginal lesion to be related to Shingrix.     It was unknown if the company considered the vaginal lesion to be related to Shingrix.   Additional Information: GSK Receipt Date: 13-JUN-2023 The reporter stated when she woke up this (on the day of reporting) morning she had a vaginal cold sore. She mentioned she had a history of genital herpes and takes Valacyclovir. Medical disclaimer, medical information phone number was provided. The reporter would like to be transferred to medical information. Did not consent to follow-up.
Information has been received from a medical assistant concerning a 14 year old female patient, who on 24-Sep-2008 was vaccinated with the first dose of GARDASIL, 0.5 mL, IM. On 26-Sep-2008, the patient was vaccinated with the second dose of GARDASIL, Lot# 660557/0072X, 0.5 mL, IM, earlier than recommended and she fainted on the second dose. Approximately 10 minutes after the second dose, that patient briefly fainted. On 26-Sep-2008, the patient recovered. Additional information has been requested.
Breakthrough case admission after 3 vaccines: Moderna 2/25/21 Lot# 025A21A; Moderna 0/26/21 Lot# 028A21A; Moderna 4/10/22 Lot# 0661K21A;
Arm pain with numbness, tingling to fingers and burning to palm of hand of injection site. Light sensitivity next morning. Redness, swelling the next day. Fatique. Nausea. General Myalgia. Headache. Tingling to face where light sensitivity was.
ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 2/20/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Patient reported feeling, dizzy, hot and nauseated at  beginning at 3:04pm , patient was given an ice pack to cool off and remove several layers of clothing to help with cooling off. Pt requested water asked to remove face mask  to help with adequate breathing. Patient was asked questions regarding medical history and medications as well as given time to rest. Patient reported feeling better after 20 minutes and requested to go home. Patient had an assistant who reported she would drive her home. RN spoke with daughter on the phone who reported patient to stay at daughter's home, however patient refused and requested to go home. Pt reported feeling much better was adamant about going home.
The patient called the pharmacy about 3 hours after receiving second Moderna Covid 19 vaccination, and stated had a rash on chest and an itchy throat.  No other symptoms, and states did not have like reaction from Covid vaccine.  Recommended to take 50mg diphenhydramine and seek medical examine if breathing troubles.
Symptoms started next day ( Sept. 16th) at 0600 upon waking up Severe Headache Severe Fatigue and weakness Severe Joint Pain and pain at sight of injection (right upper arm) Skin felt like glass  Moderate to Severe Nausea with vomiting after eating  x1  Symptoms lasted until 1030pm same day (Sept. 16th)
About ten days after receiving my vaccine, I noticed several red blotchy pimples pop up on my right side. They weren't hard, but they weren't liquid but they were itchy. The next day I had a couple more pop up again. At first I thought they were bed bug bites, but that wasn't the case. They proceeded to spread to my back at first, then to my stomach, continued to spread up to my chest and neck then down to my legs. It went down my right leg first and is now going down my left leg and left arm. It has changed it's form now, they aren't red and bumpy. When they come out, they are smaller and they do not go away. I was given Fluocinonide most recently as topical cream and it does seem to be working, but I'm also taking Prednisone. I was previously given Prednisone and Valaciclovir. I still have the bumps all over, but they are at bay right now because of the Prednisone and Fluocinonide. I am very bothered that, with the amount of doctors I've seen, most of them wouldn't even think that this could have been caused as a response to the vaccine.
weakness; a little bit of tightness in her chest; night sweats; feels out of breath; headache; arm redness and swelling; arm redness and swelling; nausea; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness), CHEST DISCOMFORT (a little bit of tightness in her chest), NIGHT SWEATS (night sweats), DYSPNOEA (feels out of breath) and HEADACHE (headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The Patient's Medical History was not provided.  Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT), TRAZODONE and ALLOPURINOL (ELAVIL [ALLOPURINOL]) for an unknown indication.    On 05-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced ASTHENIA (weakness), CHEST DISCOMFORT (a little bit of tightness in her chest), NIGHT SWEATS (night sweats), DYSPNOEA (feels out of breath), HEADACHE (headache), VACCINATION SITE ERYTHEMA (arm redness and swelling), VACCINATION SITE SWELLING (arm redness and swelling) and NAUSEA (nausea). At the time of the report, ASTHENIA (weakness) had not resolved, CHEST DISCOMFORT (a little bit of tightness in her chest), NIGHT SWEATS (night sweats), DYSPNOEA (feels out of breath), VACCINATION SITE ERYTHEMA (arm redness and swelling), VACCINATION SITE SWELLING (arm redness and swelling) and NAUSEA (nausea) outcome was unknown and HEADACHE (headache) had resolved.            Patient is also concomitantly taking a cholesterol and thyroid medication.  No treatment information was reported.   This case was linked to MOD-2021-074876 (Patient Link).
Nausea; Diarrhea; Headache; Dizziness; No appetite; Balance issues; Lungs hurt; Muscle aching; Chills; Dose 1: 27Mar2021, Dose 2: 04Apr2021; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO169) via an unspecified route of administration in the left arm on 04Apr2021 at 10:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and undifferentiated connective tissue disease (utcd). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified medication within two weeks of vaccination. The patient previously received nitrofurantoin (MACROBID) for unknown indication on an unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 27Mar2021 at 10:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. On 20Apr2021 at 10:30, the patient experienced nausea, diarrhea, headache, dizziness, no appetite, balance issues, lungs hurt, muscle aching and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea, diarrhea, headache, dizziness, no appetite, balance issues, lungs hurt, muscle aching and chills was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Tachycardia for couple of days after the vaccination. Shortness of breath since the moment of the first dose. Pain on both legs after first dose. Severe Migraines on the second dose of the vaccine that lasted for 3 weeks. Hematoma on the leg without pain, with swelling. Leg pain with warmth sensation.
Patient recd FLUZONE High-Dose 2016-17 0.5 ml on 10/6/2016 around 1pm. Pt states by about 430pm she could not raise her arm. This was reported 12/17/2016. Pt. states she has not sought medical attention but will do so because pain has not resolved and she can't put her arm behind her back or put a shirt on or have normal range of motion.
Fatigue, sore achy muscles, joints all over body, stiff achy neck, swollen lymph nodes in throat, sore throat, headache.
A report has been received from a Health Professional concerning a 28 year old, female subject, who had been receiving FLUMIST QUADRIVALENT (Intranasal). Vaccine given on same day included oseltamvir. FLUMIST QUADRIVALENT (Intranasal) started on 02-Sep-2014. The patient experienced No AE reported which started on 03-Sep-2014. The outcome of the event of no AE reported is unknown. The report was considered to be non-serious.
On april 28th I received my vaccine at 12:05 and within 5 mins I had a slight dull headache. April 29th I woke up sweaty and running fever, had sore throat and chills and runny stuffy nose, felt like a bus hit me. April 30th woke up worse, I had all the same symptoms and a cough developed. May 1st I attempted to go to work  but was so exhausted and symptoms and cough had progressed and now my chest had a full ache to it, I felt as tho something was sitting on my chest. May 2nd symptoms elevated somewhat. May 3rd symptoms elevated alot, still have slight cough, was able to return to work but was not fully myself. May 4th only have slight glen and cough.
Swelling, redness, pain & warmth at injection site, swelling approx 6"x6".  Also c/o muscle & joint aches all over. Where Pneumovax vaccine given.
COVID Toes; Dose 1 and Dose 2 Moderna, Dose 3 Pfizer; Dose 1 and Dose 2 Moderna, Dose 3 Pfizer; Dose received 3; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 18Dec2021 10:45 (Lot number: FL3197) at the age of 57 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Diabetes" (unspecified if ongoing); "high blood pressure" (unspecified if ongoing), notes: high blood pressure; "high cholesterol" (unspecified if ongoing), notes: high cholesterol. The patient took concomitant medications. Vaccination history included: Moderna vaccine (Dose Number: 2, Batch/Lot No: 007B21A, Location of injection: Arm Left), administration date: 16Apr2021, when the patient was 56 years old, for COVID-19 Immunization; Moderna vaccine (Dose Number: 1, Batch/Lot No: 040A21A, Location of injection: Arm Left), administration date: 13Mar2021, when the patient was 56 years old, for COVID-19 Immunization. The following information was reported: OFF LABEL USE (non-serious), INTERCHANGE OF VACCINE PRODUCTS (non-serious) all with onset 18Dec2021 10:45, outcome "unknown" and all described as "Dose 1 and Dose 2 Moderna, Dose 3 Pfizer"; IMMUNISATION (non-serious) with onset 18Dec2021 10:45, outcome "unknown", described as "Dose received 3"; ILL-DEFINED DISORDER (non-serious) with onset 20Dec2021, outcome "not recovered", described as "COVID Toes". The event "covid toes" was evaluated at the physician office visit. Therapeutic measures were not taken as a result of ill-defined disorder.  Additional information: Another reporter is other HCP. Patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  Follow-Up (11Jan2022): Follow-up attempts are completed. No further information is expected.
Tested positive for RSV on 11/22/2023 Exposed to an infant that tested positive to RSV.